Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.

作者: R Whittington , D Neuberg , W J Tester , A B Benson , D G Haller

DOI: 10.1200/JCO.1995.13.1.227

关键词:

摘要: PURPOSEThe purpose of this study was to determine the maximum-tolerated dose (MTD) fluorouracil (5-FU) administered as a protracted intravenous (IV) infusion with concurrent radiation in patients pancreaticobiliary carcinoma.METHODSTwenty-five recurrent, residual, or unresectable carcinoma pancreas biliary tract were treated on phase I trial IV infusions 5-FU, beginning at 200 mg/m2/d, therapy (59.4 Gy 33 fractions over 6 7 weeks). Chemotherapy began first day and continued through entire course treatment. After each cohort five had been observed, daily escalated 25-mg/m2 increments until dose-limiting toxicity encountered. An additional MTD. Clinical examination computed tomography (CT) used evaluate response patterns progression.RESULTSThe MTD 5-FU 250 mg/m2/d. The toxic...

参考文章(7)
Lionel Cohen, Katherine H. Woodruff, Frank R. Hendrickson, Parvathy D. Kurup, Joanne Mansell, Miguel Awschalom, Ivan Rosenberg, Randall K. Ten Haken, Response of pancreatic cancer to local irradiation with high-energy neutrons Cancer. ,vol. 56, pp. 1235- 1241 ,(1985) , 10.1002/1097-0142(19850915)56:6<1235::AID-CNCR2820560602>3.0.CO;2-U
C. G. Moertel, S. Frytak, R. G. Hahn, M. J. O'Connell, R. J. Reitemeier, J. Rubin, A. J. Schutt, L. H. Weiland, D. S. Childs, M. A. Holbrook, P. T. Lavin, E. Livstone, H. Spiro, A. Knowlton, M. Kalser, J. Barkin, H. Lessner, R. Mann-Kaplan, K. Ramming, H. O. Douglas, P. Thomas, H. Nave, J. Bateman, J. Lokich, J. Brooks, J. Chaffey, J. M. Corson, N. Zamcheck, Joel W. Novak, Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group Cancer. ,vol. 48, pp. 1705- 1710 ,(1981) , 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4
Richard Whittington, Lawrence Solin, Mohammed Mohiuddin, Ronald I. Cantor, Francis E. Rosato, William A. Biermann, Stephen M. Weiss, Thomas F. Pajak, Multimodality therapy of localized unresectable pancreatic adenocarcinoma Cancer. ,vol. 54, pp. 1991- 1998 ,(1984) , 10.1002/1097-0142(19841101)54:9<1991::AID-CNCR2820540934>3.0.CO;2-4
Joel E Tepper, Dirk Noyes, John M Krall, William T Sause, Harvey B Wolkov, Ralph R Dobelbower, John Thomson, Jay Owens, Gerald E Hanks, Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505 International Journal of Radiation Oncology Biology Physics. ,vol. 21, pp. 1145- 1149 ,(1991) , 10.1016/0360-3016(91)90269-A
G. Gordon Steel, Michael J. Peckham, Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. International Journal of Radiation Oncology Biology Physics. ,vol. 5, pp. 85- 91 ,(1979) , 10.1016/0360-3016(79)90044-0
John E. Byfield, Paula Calabro-Jones, Ivana Klisak, Fimi Kulhanian, Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays International Journal of Radiation Oncology Biology Physics. ,vol. 8, pp. 1923- 1933 ,(1982) , 10.1016/0360-3016(82)90451-5